TGTX
Tg Therapeutics·NASDAQ
--
--(--)
--
--(--)
TGTX Filings
Filing Date
Form Description
Form Type
2026-03-27
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-27 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-20
Form 8-K - Current report
Key Events
2026-03-20 · Key Events
Form 8-K - Current report
2026-02-27
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-02-27 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-02-26
TG Therapeutics, Inc.(TGTX)-20260226-2025 Q4 Earnings call transcript
Earnings Call
2026-02-26 · Earnings Call
TG Therapeutics, Inc.(TGTX)-20260226-2025 Q4 Earnings call transcript
2026-02-26
Form 8-K - Current report
Key Events
2026-02-26 · Key Events
Form 8-K - Current report
2026-01-29
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-29 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-13
Form 8-K - Current report
Key Events
2026-01-13 · Key Events
Form 8-K - Current report
2026-01-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-25
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-25 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
